|
TRIM32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.83210000000478E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65827999999424E-05 |
| Normal-vs-Stage2 |
6.536300E-02 |
| Normal-vs-Stage3 |
9.610500E-04 |
| Normal-vs-Stage4 |
1.035190E-01 |
| Stage1-vs-Stage2 |
3.580200E-01 |
| Stage1-vs-Stage3 |
6.431200E-01 |
| Stage1-vs-Stage4 |
7.502800E-01 |
| Stage2-vs-Stage3 |
2.545600E-01 |
| Stage2-vs-Stage4 |
4.301200E-01 |
| Stage3-vs-Stage4 |
9.823600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.19189999999259E-05 |
| Normal-vs-AfricanAmerican |
8.517200E-03 |
| Normal-vs-Asian |
2.763000E-01 |
| Caucasian-vs-AfricanAmerican |
5.490000E-01 |
| Caucasian-vs-Asian |
8.397600E-01 |
| AfricanAmerican-vs-Asian |
7.356000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62416999999193E-05 |
| Normal-vs-Female |
7.275900E-02 |
| Male-vs-Female |
6.492000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.060300E-02 |
| Normal-vs-Extreme_Weight |
6.0746999996919E-07 |
| Normal-vs-Obese |
6.171800E-04 |
| Normal-vs-Extreme_Obese |
2.976400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.947700E-02 |
| Normal_Weight-vs-Obese |
3.755800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.619200E-01 |
| Extreme_Weight-vs-Obese |
2.475000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.061000E-01 |
| Obese-vs-Extreme_Obese |
8.239200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.984100E-03 |
| Normal-vs-Age(41-60Yrs) |
5.421400E-03 |
| Normal-vs-Age(61-80Yrs) |
1.74466999999234E-05 |
| Normal-vs-Age(81-100Yrs) |
1.220810E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.834010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.693400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.918400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.825700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.698000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.555200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.85600000002228E-06 |
| Normal-VS-Type2 PRCC |
8.135100E-03 |
| Normal-VS-KIRP CIMP |
5.60920000447496E-08 |
| Normal-VS-Unclassified PRCC |
9.563800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.840800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.162800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.033500E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.259750E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.486100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.755200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.73220000000618E-05 |
| Normal-vs-N1 |
7.851900E-02 |
| Normal-vs-N2 |
4.527000E-01 |
| N0-vs-N1 |
5.400200E-01 |
| N0-vs-N2 |
2.881200E-01 |
| N1-vs-N2 |
3.448200E-01 |
|
|
